Table I.
p53 expression | ||||
---|---|---|---|---|
Parameter | Cases, n | Negative | Positive | P-value |
Age, years | >0.05 | |||
≥60 | 19 | 9 | 10 | |
<60 | 32 | 18 | 14 | |
Gender | >0.05 | |||
Female | 14 | 8 | 6 | |
Male | 37 | 19 | 18 | |
Tumor differentiation | <0.05 | |||
Well | 19 | 19 | 0 | |
Moderate | 21 | 8 | 13 | |
Poor | 11 | 0 | 11 | |
Lymph node metastasis | <0.05 | |||
No | 25 | 20 | 5 | |
Yes | 26 | 7 | 19 | |
Clinical stage | <0.05 | |||
II | 18 | 15 | 3 | |
III or IV | 33 | 12 | 21 | |
Tumor site | >0.05 | |||
Cheek | 15 | 7 | 8 | |
Floor of mouth | 14 | 8 | 6 | |
Tongue | 12 | 7 | 5 | |
Palate | 5 | 3 | 2 | |
Gum | 5 | 2 | 3 | |
Therapeutic effectiveness | <0.05 | |||
Responsive | 35 | 22 | 13 | |
Non-responsive | 16 | 5 | 11 |
χ2 test was performed for statistical analysis. P<0.05 was considered statistically significant.